NuGen Medical Devices Inc.
NGMDF
$0.068
$0.022549.45%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -212.17% | 48.70% | 28.41% | -11.18% | 4.52% |
| Total Depreciation and Amortization | -2.40% | -8.61% | 13.90% | -15.70% | 0.08% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 210.03% | -30.27% | -46.94% | 136.57% | -49.54% |
| Change in Net Operating Assets | 253.19% | -34.35% | -5.20% | -46.79% | 196.95% |
| Cash from Operations | -317.79% | 74.01% | 31.44% | -29.70% | 63.67% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | 0.00% | 99.19% | 0.80% | -- |
| Cash from Investing | 0.00% | 0.00% | 99.23% | -5.09% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 66.35% | -308.00% | 132.79% | 96.28% |
| Issuance of Common Stock | -- | -100.00% | 1,812.50% | -97.04% | -67.74% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 144,796.08% | -100.92% | 1,404.09% | -96.27% | -60.74% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | 189.64% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4,245.56% | -214.34% | 94.15% | -394.26% | -50.25% |